Hepatic IL6, which is an important proinflammatory adipocytokine that is almost always significantly elevated in the adipose cells of obese and insulin-resistant individuals and NAFLD patients, was also upregulated in the HCBD group (Fig. 5). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.